SEED Therapeutics
PrivateLast Round
Series A
Extension
Sep 23, 2025
Est. Valuation
$130M
Total Funding Raised
$80M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SEED Therapeutics is a biotechnology company that develops targeted protein degradation therapeutics using its proprietary RITE3™ molecular glue platform to treat diseases in oncology, neurodegeneration, and immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SEED Therapeutics Comparables
Compare SEED Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Degron Therapeutics | 88% | |
| Plexium | 88% | |
| Magnet Biomedicine | 88% |
SEED Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 23, 2025 | ||||
| Series A | Aug 6, 2024 | ||||
| Series A | Nov 13, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 29, 116% of headcount.
- Sep 23, 2025
$30M round led by Eisai.
Recent news
Latest coverage and updates
- receives_awardAug 17, 2026
SEED Therapeutics, Inc. received award 2025Prix Galien USA "Best Start-Up" Award on Jul 1st '25.
SEED Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SEED Therapeutics's valuation, stock price, and market status.
Is SEED Therapeutics a public or private company?
SEED Therapeutics is a private company.
What is the current stock price of SEED Therapeutics?
SEED Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is SEED Therapeutics worth (valuation)?
SEED Therapeutics's valuation is estimated at $130.0M based on funding round data.
Can I buy SEED Therapeutics stock?
SEED Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SEED Therapeutics's last funding round?
SEED Therapeutics's most recent funding round was Series A on August 6, 2024.
Who are the main investors in SEED Therapeutics?
Investor information for SEED Therapeutics is not publicly disclosed.
Will SEED Therapeutics IPO soon?
No public IPO plans have been announced for SEED Therapeutics.
How can I track SEED Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SEED Therapeutics's secondary market activity and sign up for updates.